Cargando…

Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib

The long non-coding RNA (lncRNA) LINC00460 is involved in tumor growth, metastasis and drug resistance. The present study investigated the clinical significance of LINC00460 expression in patients with epidermal growth factor receptor (EGFR) mutation-positive lung cancer treated with osimertinib. Os...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakano, Yuta, Isobe, Kazutoshi, Yoshizawa, Takahiro, Urabe, Naohisa, Homma, Sakae, Kishi, Kazuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407845/ https://www.ncbi.nlm.nih.gov/pubmed/37559586 http://dx.doi.org/10.3892/ol.2023.13966

Ejemplares similares

Clinical importance of long non-coding RNA LINC00460 expression in EGFR-mutant lung adenocarcinoma
por: Nakano, Yuta, et al.
Publicado: (2019)

Upregulated Expression of Long Non-Coding RNA, LINC00460, Suppresses Proliferation of Colorectal Cancer
por: Wang, Xin, et al.
Publicado: (2018)

LINC00460 Hypomethylation Promotes Metastasis in Colorectal Carcinoma
por: Zhang, Hui, et al.
Publicado: (2019)

Exophiala dermatitidis pneumonia with bronchiectasis required prolonged voriconazole treatment
por: Sekiguchi, Ryo, et al.
Publicado: (2021)

Long noncoding RNA 00460 (LINC00460) promotes glioma progression by negatively regulating miR‐320a
por: Feng, Li, et al.
Publicado: (2019)

LncRNA LINC00460: Function and mechanism in human cancer
por: Chen, Xi, et al.
Publicado: (2021)

Oncogenic roles of the lncRNA LINC00460 in human cancers
por: Su, Min, et al.
Publicado: (2022)

LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis
por: Li, Guangjun, et al.
Publicado: (2019)

Efficacy of three sputum specimens for the diagnosis of Mycobacterium avium complex pulmonary disease
por: Urabe, Naohisa, et al.
Publicado: (2023)

Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes
por: Yang, Jiebin, et al.
Publicado: (2020)

Long non-coding RNA LINC00460 predicts poor survival and promotes cell viability in pancreatic cancer
por: Sun, Junfeng, et al.
Publicado: (2020)

LINC00460 accelerates progression of ovarian cancer by activating transcriptional factor ZNF703
por: Wang, Xin, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma cells regulated the gemcitabine‐resistance function of CAFs by LINC00460
por: Zhu, Xiao‐Xu, et al.
Publicado: (2022)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
por: Makhlin, Igor, et al.
Publicado: (2019)

Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer
por: Lee, Jiyun, et al.
Publicado: (2022)

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance
por: Cui, Qingli, et al.
Publicado: (2022)

MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib
por: Nishiyama, Akihiro, et al.
Publicado: (2020)

Successful Treatment of EGFR-Mutant Synchronous SCLC and Lung Adenocarcinoma With Osimertinib
por: Batra, Ullas, et al.
Publicado: (2020)

Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2019)

LINC00460 Stimulates the Proliferation of Vascular Endothelial Cells by Downregulating miRNA-24-3p
por: Jia, Ruofei, et al.
Publicado: (2022)

LINC00460 Promotes Cutaneous Squamous Cell Carcinoma Progression Through Stabilizing ELAVL1 Protein
por: Xue, Chunli, et al.
Publicado: (2022)

Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1‐rearranged non‐small cell lung cancer
por: Kato, Chiaki, et al.
Publicado: (2023)

Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
por: Gen, Soei, et al.
Publicado: (2022)

Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation
por: Urabe, Naohisa, et al.
Publicado: (2022)

lncRNA LINC00460 Silencing Represses EMT in Colon Cancer through Downregulation of ANXA2 via Upregulating miR-433-3p
por: Hong, Weiwen, et al.
Publicado: (2019)

Multifocal locules including the anterior mediastinum side as a surgical indicator in pleural infection
por: Sakai, Takashi, et al.
Publicado: (2022)

EGFR‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib
por: Hara, Reina, et al.
Publicado: (2021)

Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases
por: Ye, Qiuyue, et al.
Publicado: (2023)

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
por: Hisanaga, Kaori, et al.
Publicado: (2021)

Long Noncoding RNA LINC00460 Facilitates Colorectal Cancer Progression by Negatively Regulating miR-613
por: Wang, Lei, et al.
Publicado: (2020)

Fibrocellular non‐specific interstitial pneumonia with favourable prognosis in clinically amyopathic dermatomyositis
por: Yoshizawa, Takahiro, et al.
Publicado: (2016)

Outcomes and prognosis of progressive pulmonary fibrosis in patients with antineutrophil cytoplasmic antibody-positive interstitial lung disease
por: Sakamoto, Susumu, et al.
Publicado: (2023)

LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus
por: Jiang, Yingying, et al.
Publicado: (2019)

The long non-coding RNA LINC00460 predicts the prognosis and promotes the proliferation and migration of cells in bladder urothelial carcinoma
por: Wen, Lijie, et al.
Publicado: (2019)

Long Noncoding RNA LINC00460 Facilitates Colorectal Cancer Progression by Negatively Regulating miR-613 [Corrigendum]
Publicado: (2021)

Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
por: Roper, Nitin, et al.
Publicado: (2020)

ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
por: Ortega-Franco, Ana, et al.
Publicado: (2022)

LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer
por: Meng, Xiangfeng, et al.
Publicado: (2020)

Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol
por: Zang, Hongjing, et al.
Publicado: (2020)

Survival benefit of combinatorial osimertinib rechallenge and entrectinib in an EGFR‐mutant NSCLC patient with acquired LMNA‐NTRK1 fusion following osimertinib resistance
por: Wang, Jiao‐Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uboel84g7dvc9mi56ef6pd42f4